Bioengineered heparin

References

• Hemker HC, Béguin S. Standard and method independent units for heparin anticoagulant activities. Thromb Haemost 1993; 70:724 - 8; PMID: 8128425
   PubMed Web of Science ®Google Scholar
• Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008; 358:2457 - 67; http://dx.doi.org/10.1056/NEJMoa0803200; PMID: 18434646
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Food and Drug Administration, Center for Veterinary Medicine (CVM) CfDaRHC. Guidance for Industry: Heparin for drug and medical device use: Monitoring crude heparin quality. 2013.
   Google Scholar
• Lindahl U, Rodén L. The chondroitin 4-sulfate-protein linkage. J Biol Chem 1966; 241:2113 - 9; PMID: 4287762
   PubMed Web of Science ®Google Scholar
• Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson LA, Linker A. Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A 1979; 76:3198 - 202; http://dx.doi.org/10.1073/pnas.76.7.3198; PMID: 226960
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. The sequence of the human genome. Science 2001; 291:1304 - 51; http://dx.doi.org/10.1126/science.1058040; PMID: 11181995
   PubMed Web of Science ®Google Scholar
• Levi-Schaffer F, Austen KF, Gravallese PM, Stevens RL. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci U S A 1986; 83:6485 - 8; http://dx.doi.org/10.1073/pnas.83.17.6485; PMID: 3462707
   PubMed Web of Science ®Google Scholar
• Walenga JM, Fareed J, Jeske WP, Frapaise FX, Bick RL, Samama MM. Development of a synthetic heparin pentasaccharide: Fondaparinux. Turkish J Haematol 2002; 19:137 - 50
   PubMedGoogle Scholar
• Thacker BE, Xu D, Lawrence R, Esko JD. Heparan sulfate 3-O-sulfation: A rare modification in search of a function. Matrix Biol 2014; 35:60 - 72; http://dx.doi.org/10.1016/j.matbio.2013.12.001; PMID: 24361527
   PubMed Web of Science ®Google Scholar
• Shworak NW, HajMohammadi S, de Agostini AI, Rosenberg RD. Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. Glycoconj J 2002; 19:355 - 61; http://dx.doi.org/10.1023/A:1025377206600; PMID: 12975616
   PubMed Web of Science ®Google Scholar
• Rebustini IT, Hayashi T, Reynolds AD, Dillard ML, Carpenter EM, Hoffman MP. miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. Development 2012; 139:191 - 202; http://dx.doi.org/10.1242/dev.070151; PMID: 22115756
   PubMed Web of Science ®Google Scholar
• Kolset SO, Kjellen L, Lindahl U, Seljelid R. Glycosaminoglycans produced by cultured human monocytes. Coll Relat Res 1983; 3:75
   Google Scholar
• Ledin J, Staatz W, Li JP, Götte M, Selleck S, Kjellén L, Spillmann D. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem 2004; 279:42732 - 41; http://dx.doi.org/10.1074/jbc.M405382200; PMID: 15292174
   PubMed Web of Science ®Google Scholar
• Kolset SO, Tveit H. Serglycin--structure and biology. Cell Mol Life Sci 2008; 65:1073 - 85; http://dx.doi.org/10.1007/s00018-007-7455-6; PMID: 18066495
   PubMed Web of Science ®Google Scholar
• Lin F, Lian G, Zhou Y. Synthesis of Fondaparinux: modular synthesis investigation for heparin synthesis. Carbohydr Res 2013; 371:32 - 9; http://dx.doi.org/10.1016/j.carres.2013.01.003; PMID: 23474455
   PubMed Web of Science ®Google Scholar
• Baik JY, Wang CL, Yang B, Linhardt RJ, Sharfstein S. Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells. Bioengineered 2012; 3:227 - 31; http://dx.doi.org/10.4161/bioe.20902; PMID: 22714556
   PubMed Web of Science ®Google Scholar
• Datta P, Li G, Yang B, Zhao X, Baik JY, Gemmill TR, Sharfstein ST, Linhardt RJ. Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site. J Biol Chem 2013; 288:37308 - 18; http://dx.doi.org/10.1074/jbc.M113.519033; PMID: 24247246
   PubMed Web of Science ®Google Scholar
• Chen J, Avci FY, Muñoz EM, McDowell LM, Chen M, Pedersen LC, Zhang L, Linhardt RJ, Liu J. Enzymatic redesigning of biologically active heparan sulfate. J Biol Chem 2005; 280:42817 - 25; http://dx.doi.org/10.1074/jbc.M504338200; PMID: 16260789
   PubMed Web of Science ®Google Scholar
• Lindahl U, Li JP, Kusche-Gullberg M, Salmivirta M, Alaranta S, Veromaa T, Emeis J, Roberts I, Taylor C, Oreste P, et al. Generation of “neoheparin” from E. coli K5 capsular polysaccharide. J Med Chem 2005; 48:349 - 52; http://dx.doi.org/10.1021/jm049812m; PMID: 15658847
   PubMed Web of Science ®Google Scholar
• Gasimli L, Glass CA, Datta P, Yang B, Li G, Gemmill TR, Baik JY, Sharfstein ST, Esko JD, Linhardt RJ. Bioengineering murine mastocytoma cells to produce anticoagulant heparin. Glycobiology 2014; 24:272 - 80; http://dx.doi.org/10.1093/glycob/cwt108; PMID: 24326668
   PubMed Web of Science ®Google Scholar
• Ori A, Wilkinson MC, Fernig DG. A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J Biol Chem 2011; 286:19892 - 904; http://dx.doi.org/10.1074/jbc.M111.228114; PMID: 21454685
   PubMed Web of Science ®Google Scholar